title: Therapeutics: new drugs hit the target.
authors.forename: Jana
authors.initials: J
authors.lastname: Schlütter
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D016174:Hepacivirus / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000821:virology; D006575:Heterocyclic Compounds, 3-Ring / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D009842:Oligopeptides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011392:Proline / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use; D000069616:Simeprevir; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D006575:Heterocyclic Compounds, 3-Ring; D016898:Interferon-alpha; D009842:Oligopeptides; D013449:Sulfonamides; D012254:Ribavirin; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline; D000069616:Simeprevir